198 related articles for article (PubMed ID: 10924795)
1. Adjuvant effects of sulfolipo-cyclodextrin in a squalane-in-water and water-in-mineral oil emulsions for BHV-1 vaccines in cattle.
Romera SA; Hilgers LA; Puntel M; Zamorano PI; Alcon VL; Dus Santos MJ; Blanco Viera J; Borca MV; Sadir AM
Vaccine; 2000 Aug; 19(1):132-41. PubMed ID: 10924795
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of a BHV-1/BEFV bivalent vaccine against bovine herpesvirus type 1 infection in cattle.
Chung YC; Shen HY; Cheng LT; Liu SS; Chu CY
Res Vet Sci; 2016 Dec; 109():161-165. PubMed ID: 27892866
[TBL] [Abstract][Full Text] [Related]
3. Sulfolipo-cyclodextrin in squalane-in-water as a novel and safe vaccine adjuvant.
Hilgers LA; Lejeune G; Nicolas I; Fochesato M; Boon B
Vaccine; 1999 Jan; 17(3):219-28. PubMed ID: 9987157
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of intranasal vaccination with a multivalent vaccine containing temperature-sensitive modified-live bovine herpesvirus type 1 for protection of seronegative and seropositive calves against respiratory disease.
Mahan SM; Sobecki B; Johnson J; Oien NL; Meinert TR; Verhelle S; Mattern SJ; Bowersock TL; Leyh RD
J Am Vet Med Assoc; 2016 Jun; 248(11):1280-6. PubMed ID: 27172345
[TBL] [Abstract][Full Text] [Related]
5. Bovine recombinant interleukin-2 augments immunity and resistance to bovine herpesvirus infection.
Reddy PG; Blecha F; Minocha HC; Anderson GA; Morrill JL; Fedorka-Cray PJ; Baker PE
Vet Immunol Immunopathol; 1989 Nov; 23(1-2):61-74. PubMed ID: 2559538
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
[TBL] [Abstract][Full Text] [Related]
7. Modification of active immunization with live bovine herpesvirus 1 vaccine by passive viral antibody.
Patel JR; Shilleto RW
Vaccine; 2005 Jul; 23(31):4023-8. PubMed ID: 15916839
[TBL] [Abstract][Full Text] [Related]
8. Relative efficacy of inactivated bovine herpesvirus-1 (BHV-1) vaccines.
Patel JR
Vaccine; 2005 Jul; 23(31):4054-61. PubMed ID: 15951068
[TBL] [Abstract][Full Text] [Related]
9. A novel non-mineral oil-based adjuvant. II. Efficacy of a synthetic sulfolipopolysaccharide in a squalane-in-water emulsion in pigs.
Hilgers LA; Platenburg PL; Luitjens A; Groenveld B; Dazelle T; Weststrate MW
Vaccine; 1994 May; 12(7):661-5. PubMed ID: 8085386
[TBL] [Abstract][Full Text] [Related]
10. Serological response in cattle immunized with inactivated oil and Algel adjuvant vaccines against infectious bovine rhinotracheitis.
Kamaraj G; Rana SK; Srinivasan VA
New Microbiol; 2009 Apr; 32(2):135-41. PubMed ID: 19579689
[TBL] [Abstract][Full Text] [Related]
11. Humoral immune response and assessment of vaccine virus shedding in calves receiving modified live virus vaccines containing bovine herpesvirus-1 and bovine viral diarrhoea virus 1a.
Fulton RW; Saliki JT; Burge LJ; Payton ME
J Vet Med B Infect Dis Vet Public Health; 2003 Feb; 50(1):31-7. PubMed ID: 12710498
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a combination viral vaccine for protection of cattle against experimental infection with field isolates of bovine herpesvirus-1.
Ellis JA; Gow SP; Goji N; Jones C; Workman A; Henderson G; Rhodes C; Alaniz G; Meinert TR; Tucker CM
J Am Vet Med Assoc; 2009 Sep; 235(5):563-72. PubMed ID: 19719449
[TBL] [Abstract][Full Text] [Related]
13. Rapid onset of protection following vaccination of calves with multivalent vaccines containing modified-live or modified-live and killed BHV-1 is associated with virus-specific interferon gamma production.
Woolums AR; Siger L; Johnson S; Gallo G; Conlon J
Vaccine; 2003 Mar; 21(11-12):1158-64. PubMed ID: 12559793
[TBL] [Abstract][Full Text] [Related]
14. Anti-bovine herpesvirus and anti-bovine viral diarrhea virus antibody responses in pregnant Holstein dairy cattle following administration of a multivalent killed virus vaccine.
Smith BI; Rieger RH; Dickens CM; Schultz RD; Aceto H
Am J Vet Res; 2015 Oct; 76(10):913-20. PubMed ID: 26413830
[TBL] [Abstract][Full Text] [Related]
15. Identification of a mutant bovine herpesvirus-1 (BHV-1) in post-arrival outbreaks of IBR in feedlot calves and protection with conventional vaccination.
van Drunen Littel-van den Hurk S; Myers D; Doig PA; Karvonen B; Habermehl M; Babiuk LA; Jelinski M; Van Donkersgoed J; Schlesinger K; Rinehart C
Can J Vet Res; 2001 Apr; 65(2):81-8. PubMed ID: 11346260
[TBL] [Abstract][Full Text] [Related]
16. Immunopotentiation of bovine respiratory disease virus vaccines by interleukin-1 beta and interleukin-2.
Reddy DN; Reddy PG; Xue W; Minocha HC; Daley MJ; Blecha F
Vet Immunol Immunopathol; 1993 Jun; 37(1):25-38. PubMed ID: 8393601
[TBL] [Abstract][Full Text] [Related]
17. No vaccine interference between bovine coronavirus and bovine herpesvirus-1 in a randomized trial when coadministrating two intranasal modified-live viral vaccines to neonatal calves.
Bolton MW; Nordstrom S; Hill K; Midla L; Rajamanikam K; Griebel PJ
Am J Vet Res; 2024 May; 85(5):. PubMed ID: 38457927
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of experimental subunit vaccines for infectious bovine rhinotracheitis.
Lupton HW; Reed DE
Am J Vet Res; 1980 Mar; 41(3):383-90. PubMed ID: 6245609
[TBL] [Abstract][Full Text] [Related]
19. BHV-1 vaccine induces cross-protection against BHV-5 disease in cattle.
Del Médico Zajac MP; Puntel M; Zamorano PI; Sadir AM; Romera SA
Res Vet Sci; 2006 Dec; 81(3):327-34. PubMed ID: 16540133
[TBL] [Abstract][Full Text] [Related]
20. Comparative studies of BHV-1 variants by in vivo--in vitro tests.
Bratanich AC; Sardi SI; Smitsaart EN; Schudel AA
Zentralbl Veterinarmed B; 1991 Feb; 38(1):41-8. PubMed ID: 1648293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
